Skip to main content
OpenTrials

Clinical trial condition

Rheumatoid Arthritis

Explore clinical trials studying Rheumatoid Arthritis. Study availability and eligibility vary by location and protocol.

1,866 public trials 127 recruiting studies
Refine in advanced search Browse all conditions

Rheumatoid Arthritis trial results

Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01521923

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • 209 Birmingham, Alabama, United States
  • 170 Huntsville, Alabama, United States
  • 180 Mobile, Alabama, United States
  • 247 Glendale, Arizona, United States
View all 178 locations
View Trial Details
Completed

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

NCT01519791

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • 209 Birmingham, Alabama, United States
  • 170 Huntsville, Alabama, United States
  • 180 Mobile, Alabama, United States
  • 247 Glendale, Arizona, United States
View all 178 locations
View Trial Details
Completed

A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.

NCT02679001

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Arvika Sjukhus; Reumatologimottagningen - Medicinmottagningen Arvika, Sweden
  • Mälarsjukhuset; Reumatologkliniken Eskilstuna, Sweden
  • Karolinska University Hospital, Huddinge; Rheumatology Huddinge, Sweden
  • Blekingesjukhuset Karlskrona; Medicin, Rheumatology Karlskrona, Sweden
View Trial Details
Completed

A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy

NCT00785928

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntsville, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calabasas, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Upland, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vero Beach, Florida, United States
View all 48 locations
View Trial Details
Completed

Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))

NCT01163292

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Site Reference ID/Investigator# 54680 Anjo, Japan
  • Site Reference ID/Investigator# 54677 Aomori, Japan
  • Site Reference ID/Investigator# 54516 Chiba, Japan
  • Site Reference ID/Investigator# 54660 Chiba, Japan
View all 75 locations
View Trial Details
Completed

Prednisone Timed-Release Tablet (TRT) Study: Modified-Release (MR) Formulation of Prednisone Compared to Standard Immediate-Release (IR) Prednisone in Participants With Rheumatoid Arthritis

NCT00146640

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Research Site Aachen, Germany
  • Research Site Bad Kreuznach, Germany
  • Research Site Berlin, Germany
  • Research Site Cologne, Germany
View all 24 locations
View Trial Details
Completed

The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

NCT01163617

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +7 more
Locations
  • Site Reference ID/Investigator# 27144 Victorville, California, United States
  • Site Reference ID/Investigator# 27153 Tampa, Florida, United States
  • Site Reference ID/Investigator# 27150 Passaic, New Jersey, United States
  • Site Reference ID/Investigator# 27143 Duncansville, Pennsylvania, United States
View Trial Details

Related conditions